alexa Remineralizing Agent -Then and Now -An Update | OMICS International
ISSN: 2161-1122

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Remineralizing Agent -Then and Now -An Update

Naveena Preethi P*, Nagarathana C and Sakunthala BK

Department of Pedodontics and Preventive Dentistry, Rajarajeswari Dental College and Hospital, Kumbalgodu, Mysore Road, Bangalore, India

*Corresponding Author:
Naveena Preethi P
Postgraduate Student
Department of Pedodontics and Preventive Dentistry
Rajarajeswari Dental College and Hospital
Kumbalgodu, Mysore Road, Bangalore-560074, India
Tel: +91 9844066427
E-mail: [email protected]

Received date: September 03, 2014; Accepted date: October 20, 2014; Published date: October 27, 2014

Citation: Naveena P, Nagarathana C, Sakunthala BK (2014) Remineralizing Agent -Then and Now -An Update. Dentistry 4:256. doi:10.4172/2161-1122.1000256

Copyright: © 2014 Naveena P, et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Dentistry


Dental caries is a highly prevalent multifactorial disease and has been a major public health problem for many centuries. The goal of modern dentistry is to manage non-cavitated caries lesions non-invasively through remineralization in an attempt to prevent disease progression and improve aesthetics, strength, and function. Remineralization is defined as the process whereby calcium and phosphate ions are supplied from an externalsource to the tooth thereby converting ion deposition into crystal voids in demineralized enamel, thus producing net mineral gain. Biomimetic approaches to stabilization of bioavailable calcium, phosphate, and fluoride ions and the localization of these ions to non-cavitated caries lesions for controlled remineralization shows great promise for the non-invasive management of dental caries. The aim of this article is to give a brief update about current remineralization agent aiming to “treat early caries lesion" noninvasively.


Early carious lesion; Non-invasive treatment; Remineralizing agent


Worldwide contribution of dental caries to the burden of oral diseases is about 10 times higher than that of periodontal disease, than other common oral conditions [1]. Owing to its globally high prevalence, dental caries is a 'pandemic' disease characterized by a high percentage of untreated carious cavities causing pain, discomfort and functional limitations [2]. Untreated carious cavities, furthermore, has significant impact on the general health of children and on social and economic wellbeing of communities [3].

A surgical approach for the elimination of carious lesion was developed only a century ago; this approach was necessary during that time, because there was no valid alternative. The focus on caries has recently shifted to the development of methodologies for the detection of the early stages of caries lesions and the use of non-invasive treatment for these lesions. The non-invasive treatment of early carious lesions by remineralization has the potential to be a major advance in the clinical management of the disease.

Remineralization of white-spot lesions and carious lesions may be possible with a variety of currently available agents containing fluoride, bioavailable calcium and phosphate, and casein phosphopeptide in-amorphous calcium phosphate, self-assembling peptide. The current concept further bridges the traditional gap between prevention, non-invasive and surgical procedures which is just what dentistry needs for the current age.


Demineralization occurs by disassociation of lactic acid, produced by bacterial carbohydrate metabolism, with tooth mineral. This reaction leads to release of mineral ions into the solution.

Ca10(PO4)6(OH)2 + 14 H+ → 10 Ca+ + 6 H2PO4+ H2O

The extent to which tooth mineral dissolves in a given solution is governed by thermodynamic ion activityproduct (IAP).

IAP = (Ca2+)10(PO43)6(OH)2

When the IAP equals a constant called the solubility product constant of Ksp, the solution is in equilibriumwith the solid and is said to be saturated with respect to the solid [4]. The only requirement for dimeralization to occur is that the IAP in the demineralizing solution should be less than the Ksp.

(Ca2+)10(PO4 3)6(OH-)2 < Ksp (tooth mineral)

The subsurface lesion is reversible via a remineralization process. This is by the increase in oral fluid calcium and phosphate that drives the remineralizationprocess.

Enamel demineralization in the presence of (F) Fluoride in dental biofilm: Sugars (sucrose, glucose, fructose) are converted to acids in the biofilm. When the pH decreases to below 5.5, undersaturation happens with respect to hydroxyapatite (HA) and then reaches the biofilm fluid, resulting in mineral dissolution. However, if the pH is higher than 4.5 and F is present,the biofilm fluid is supersaturated with respect to fluorapatite (FA) and there is reprecipitation of minerals in the enamel. As a consequence, the net demineralization is reduced [5] (Figure 1).


Figure 1: Demineralization by Fluoride (In dental Biofilm)

Enamel remineralization in the presence of F in dental biofilm. After the exposure to sugars has ceased, acids in the biofilm are cleared by saliva and converted to salts. As a result, the pH increases and, at 5.5 or higher, the biofilm fluid is supersaturated with respect to HA and FA. If the biofilm still contains F, then thelost Ca and Pby enamel can be recovered more efficiently [5] (Figure 2).


Figure 2: Remineralization by Fluoride (In dental Biofilm)

Ideal requirements of a remineralizing agent

• Should deliver calcium and phosphate into the subsurface

• Should not deliver any excess of calcium

• Should not favor calculus formation

• Should work at an acidic pH so as to stop demineralization during a carious attack

• Should work in xerostomic patients also, as saliva cannot effectively stop the

carious process

• Should be able to boost the remineralizing properties of saliva

• The novel materials should be able to show some benefits over fluoride [6].


An adjunct to preventive therapyfor reducing caries in high-risk patients

• Reduce dental erosion in patients with gastric reflux or other disorders

• To reduce decalcification in orthodontic patients

• To repair enamel in cases involving whitespot lesions

• For fluorosis, before and after teeth whitening and to desensitize sensitive teeth [7].

Past remineralizing agent-fluorides

The first set of theories concerning the mechanism of action of fluoride was based exclusively on its pre-eruptive effect. Arnold, in 1957, was the first author to mention the post-eruptive effect of fluoride in the drinking water and the ability of topical fluoride to reduce the incidence of caries [4-8].

The mechanism by which fluoride increases caries resistance may arise from both systemic and topical applications of fluoride and can be broadly grouped as follows - increased enamel resistance, increased rate of maturation, remineralization of incipient caries, interference with micro-organisms and improved tooth morphology [8].

Casein Phosphopeptide - Amorphous Calcium Phosphate

The casein phosphopeptides (CPPs) are produced from the tryptic digest of casein, aggregated with calcium phosphate and purified through ultrafiltration [6]. Casein has the ability to stabilize calcium and phosphate ions by releasing small sequences of peptides (CPPs) through partial enzymic digestion that leads to the development of a remineralization technology based on casein phosphopeptide-stabilized amorphous calcium phosphate complexes (CPP-ACP) and casein phosphopeptide-stabilized amorphous calcium fluoride phosphate complexes (CPP -ACFP) [9,10].

This technology was developed by Eric Reynolds, Australia. CPPs contain the cluster sequence of –Ser (P)-Ser (P)- Ser (P)- Glu-Glu from casein [11,12]. This protein nanotechnology combines the precise ratio of 144 calcium ions plus 96 phosphate ions and six peptides of CPP.

The size and electro neutrality of the CPP nanocomplexes allows them to diffuse down the concentration gradient into the body of the sub-surface lesion [9,10]. Once present in the enamel sub-surface lesion, the CPP-ACP releases the weakly bound calcium and phosphate ions [13,14], depositing them into crystal voids. The CPPs have a high binding affinity for apatite [15] thus, on entering the lesion, the CPPs binds to the more thermodynamically favored surface of an apatite crystal face.

It is pH responsive, i.e. with increasing pH, the level of bound ACP increases, stabilizing free calcium and phosphate and thus provides an anti-calculus action [16]. The anti-caries action influences the properties and behavior of dental plaque through (1) binding with adhesion molecules in mutans Streptococci, impairing their incorporation into plaque, (2) elevating plaque calcium ion levels to inhibit plaque fermentation and (3) providing protein and phosphate buffering of plaque fluid pH to suppress overgrowth of aciduric species when fermentable carbohydrate is in excess.

Tooth crèmes using CPP-ACP (Recaldent technology) such as MIPaste and ToothMousse16 recognizes the importance of the neutral ion species, gaining access to the sub-surface lesion through porous enamel surface. This is the reason why arrested white spot lesions should have a surface etching treatment before remineralization with Recaldent products, unlike fluoride treatments with conventional dentifrices (1000 ppm) that deposits surface mineral but do not eliminate a white-spot lesion [17].

CPP-ACP is a useful cario-static agent for the control of dental caries [7]. A dentifrice containing CPP-ACP with fluoride will provide remineralization, which is superior to both CPP-ACP and to conventional and high fluoride dentifrices [18]. Studies done by Reynolds and colleagues also found a reduction of 15% and 46%, respectively, in 0.1% and 1.0% w/v CPP-ACP [19].

Thus, it is evident that other than fluoride, the strongest clinical evidence for remineralization is CPP-based Recaldent technology, with both long-term, large-scale clinical trials and randomized controlled clinical trials further supporting its efficacy.

Bioactive glass

Bioactive glass (Bioglass®) was invented by Dr. Larry Hench in1960s. It acts as a biomimetic mineralizer matching the body’s own mineralizing traits and also affecting cell signals thereby benefitting the restoration of tissue structure and function [20].

Bioglass® in an aqueous environment immediately begins surface reaction in three phases-leaching and exchange of cations, network dissolution of SiO2 and precipitation of calcium and phosphate forming an apatite layer. The critical stages for glass surface reactions are the initial Na+ and H+/H3O+ ion exchange and de-alkalinization of the glass surface layer which is quite rapid, within minutes of implantation and exposure to body fluids [21]. The net negative charge on the surface and loss of sodium causes localized breakdown of the silica network with the resultant formation of (silanol) Si (OH) groups, which then repolymerizes into a silica-rich surface layer [22]. Within 3-6 h in vitro, the calcium phosphate layer will crystallize into the carbonated hydroxyl apatite (CAP) layer, which essentially is the bonding layer. Chemically and structurally, this apatite is nearly identical to bone and tooth mineral. These Bioglass® surface reactions from implantation to formation of 100-150 µm CAP layer takes 12-24 h [21-23].

Bioactive glass formulation commonly used in research studies contains 45 wt% SiO2 4.5 wt% Na2O and CaO and 6 wt% P2O5. The network breakdown of silica depends upon the concentration of SiO2 and is time dependent. Thus, keeping the silica below 60 wt% and maintaining a high CaO/P2O5 ratio guarantees a highly reactive surface.

Novamin®, a trade name for bioactive glass, is manufactured by Novamin Technologies Inc. (Alachua, FL, USA). It has been demonstrated that, fine particulate bioactive glasses (<90 µm) incorporated into an aqueous dentifrice has the ability to clinically reduce the tooth hypersensitivity through the occlusion of dentinal tubules by the formation of the CAP layer [24]. Investigators using bioactive glass compositions have demonstrated a significant anti-microbial effect toward caries pathogens (S. mutans, S. sanguis) upon exposure to bioactive glass powders as well as solutions and extracts [25].

Caries can also result from inadequate saliva, without which fluoride is limited by value [26]. Thus, individuals who experience reduced calcium, phosphate and fluoride ions caused by hyposalivation can benefit from the use of bioactive glass. In addition, women are at increased caries risk due to inadequate salivary calcium levels at different points in their lives, including ovulation, pregnancy and post-menopause, resulting in the same net effect as reduced saliva fluoride efficacy.

Thus, the use of bioactive glass (Novamin Technology) in remineralization of enamel is quite promising, especially in patients with systemic problems, but further research needs to be undertaken to prove its efficacy.

Tri-calcium phosphate [clinprotooth crème]

TCP is a new hybrid material created with a milling technique that fuses beta tricalcium phosphate (ß-TCP) and sodium lauryl sulfate or fumaric acid. This blending results in “functionalized” calcium and a “free” phosphate, designed to increase the efficacy of fluoride remineralization [27,28]. ß-TCP is similar to apatite structure and possesses unique calcium environments capable of reacting with fluoride and enamel. When the phosphate floats freely, the exposed calcium environments are protected by preventing the calcium from prematurely interacting with fluoride. TCP provides catalytic amounts of calcium to boost fluoride efficacy and may be well designed to coexist with fluoride in a mouth rinse or dentifrice because it will not react before reaching the tooth surface [29]. When TCP finally comes into contact with the tooth surface and is moistened by saliva, the protective barrier breaks down, making the calcium, phosphate and fluoride ions available to the teeth. The fluoride and calcium then reacts with weakened enamel to provide a seed for enhanced mineral growth relative to fluoride alone.

Products available with TCP include a 5000 ppm sodium fluoride dentifrice and a 5% sodium fluoride varnish. Studies have concluded that TCP provided superior surface and sub-surface remineralization compared with a 5000 ppm fluoride and CPP-ACP [30]. There has been no significant research on TCP combined with fluoride varnish. All published studies supporting this material has been invitro studies. The potential of TCP is promising, but more studies are needed, including clinical trials supporting its efficacy in boosting remineralization.

ACP Technology [enamelon, enamel care]

The ACP technology requires a two-phase delivery system to keep the calcium and phosphorous components from reacting with each other before use. The current sources of calcium and phosphorous are two salts, calcium sulfate and dipotassium phosphate. When the two salts are mixed, they rapidly form ACP that can precipitate over the tooth surface. This precipitated ACP can then readily dissolve into the saliva and can be available for tooth remineralization [31].

The ACP technology was developed by Dr. Ming S. Tung. In 1999, ACP was incorporated into toothpaste called Enamelonand later reintroduced in 2004 as Enamel Care toothpaste [32].There is modest evidence for Enamelon™ on caries inhibitory action [33].

An inherent technical issue with Enamelon™ is that calcium and phosphate are not stabilized, thus allows the two ions to combine into insoluble precipitates before they come into contact with saliva or enamel. This is unlike Recaldent™, which has the casein phosphoproteins to stabilize calcium and phosphate.

Self assembling peptide

Recent developments in tissue engineering, material sciences and stem cell research offer considerable potential to dental therapies. Peptide treatment for early caries lesion is the area of current research.

Peptide treatment significantly increases net mineral gain due to a combined effect of increased mineral gain and inhibition of mineral loss. Rationally designed β-sheet-forming peptides P114 that self-assemble themselves to form three-dimensional scaffolds under defined environmental conditions have been shown to nucleate hydroxyl apatite de novo and to have potential applications in mineralized tissue regeneration, mimicking the action of enamel matrix proteins during tooth development. Results suggest that a single application of P114 can be beneficial in the treatment of early caries lesions and that self assembling peptides are candidate materials for mineralized tissue regeneration and repair [34].

Anionic P114 is a rationally-designed self-assembling peptide [35,36]. Self-assembling peptides undergo well-characterized hierarchial self-assembly as three-dimensional fibrillar scaffolds in response to specific environmental triggers, offering a new generation of well-defined biopolymers with a range of potential applications. At certain peptide concentrations P114 switches from a low viscosity isotropic liquid to an elastomeric nematic gel (pH <7.4) then the anionic groups of the P114 side chains would attract Ca++ ions, inducing de novo precipitation of hydroxyl apatite inducing mineral deposition in situ [37].

P114 is safe, non-invasive and acceptable to patients. The treatment differs from other ‘filling without drilling’. The use of a biomimetic peptide such as P114 has the additional advantage of effecting ‘natural’ repair by regenerating the mineral itself. P114 is a well-tolerated treatment, and currently designed to test ‘next generation’ peptides to accelerate the repair process, thus making ‘filling without drilling’ a reality [37].

In a recent study by Schlee et al. also proved that when P114 is applied to the tooth the peptide diffuses into the subsurface microproes and forms a 3 D scaffold which is made up of small fibers these scaffold mimies proteins found in teeth development and supports hydroxyl apatite cryteststallisation around it to regenerate tooth enamel over a period of three months [38], another invitro study which evaluated the efficacy of the newly introduced self-assembling peptide P114 (curodontTM) for regenerating demineralized tooth tissue on smooth surface also showed significant results based on test and control group after 8 and 12 weeks [39].


The relationship by which remineralization could occur more favorably can be understood, only by clearly knowing the mode of implementing these remineralizing agents. Thus it is important for dental professionals to be aware of these techniques and know, that it takes significant time to establish the bonafides of a new technology like this. And further requires more detailed clinical knowledge and trials along with a “watching brief” methodology necessary for this rapidly progressing area of dental science.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 16437
  • [From(publication date):
    November-2014 - Jul 20, 2018]
  • Breakdown by view type
  • HTML page views : 11921
  • PDF downloads : 4516

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7